MCP
RXST icon

Militia Capital Partners’s RxSight RXST Stock Holding History

Militia Capital Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-110,900
Closed -$1.44M – 216
2025
Q2 		$1.44M Buy
110,900
+80,900
+270% +$1.22M 0.67% 39
2025
Q1 		$758K Buy
+30,000
New +$892K 0.6% 44

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Militia Capital Partners's RXST Position: Q3 2025 in Review

Militia Capital Partners sold out of RxSight (RXST) in Q3 2025, closing a stake of 110,900 shares — an estimated $1.44M sold.

Militia Capital Partners first reported a position in RXST in Q1 2025 and held it in 2 quarters. The position peaked at $1.44M in Q2 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Militia Capital Partners reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Militia Capital Partners sold 110,900 RxSight shares in Q3 2025, an estimated $1.44M.
  • Militia Capital Partners first reported a position in RxSight in Q1 2025 and held it in 2 quarters.
  • Militia Capital Partners's RxSight position peaked at $1.44M in Q2 2025.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Militia Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.